Ledger.Open graph →
SEC Form D · Amendment · filed December 24, 2013

Blend Therapeutics, Inc

Offering
$21.0M
Sold
$21.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark Iwicki · Watertown, MAExec · DirectorWilliam A. Skeean · Atlanta, GADirectorPaul R. Izlar · Atlanta, GADirectorA. Douglas R. Mcgregor · TORONTO, Ontario, CanadaDirectorAlan K. Walbeck · Sandy, UTDirectorIvan Gowan · Hamilton, NYDirectorTim A. Woolaver · George Town, Cayman IslandsDirectorScott E. Rudderham · Saskatoon, Saskatchewan, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗